Back to Search Start Over

Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies

Authors :
Dingwei Ye
Axel Heidenreich
Aaron Dahmen
Filippo Pederzoli
Alberto Briganti
Maarten Albersen
Mario Catanzaro
Roberto Salvioni
Antonio Augusto Ornellas
Philippe E. Spiess
Michael Ager
Laura Marandino
Nicholas H. Chakiryan
Friederike Haidl
Eduard Roussel
Marco Bandini
Jad Chahoud
Nick Watkin
Oliver W. Hakenberg
Yao Zhu
Andrea Necchi
Francesco Montorsi
Chakiryan, Nicholas H
Dahmen, Aaron
Bandini, Marco
Pederzoli, Filippo
Marandino, Laura
Albersen, Maarten
Roussel, Eduard
Zhu, Yao
Ye, Ding-Wei
Ornellas, Antonio A
Catanzaro, Mario
Hakenberg, Oliver W
Heidenreich, Axel
Haidl, Friederike
Watkin, Nick
Ager, Michael
Chahoud, Jad
Briganti, Alberto
Salvioni, Roberto
Montorsi, Francesco
Necchi, Andrea
Spiess, Philippe E
Source :
The Journal of urology. 206(4)
Publication Year :
2021

Abstract

PURPOSE: Our primary objective is to detail the incidence, site, and timing of penile squamous cell carcinoma (pSCC) recurrence after inguinal lymph node dissection (ILND). MATERIALS AND METHODS: We performed a retrospective analysis of 551 patients who underwent ILND for pSCC from 2000 to 2017. The primary outcome was pSCC recurrence after ILND. Recurrences were identified and stratified by site. Timing of recurrence was determined. Multivariable logistic regression analysis determined associations with recurrence. Multivariable Cox regression analysis determined associations with overall survival (OS). Sub-group analysis of the distant recurrences analyzed timing and OS by site of distant recurrence. RESULTS: After ILND pSCC recurred in 176 (31.9%) patients. Median time to recurrence was 10 months for distant recurrences, 12 for inguinal, 10.5 for pelvic, and 44.5 for local. Greater than 95% of distant, inguinal, and pelvic recurrences occurred within 48 months of ILND, versus 127 months for local recurrences. Post-ILND recurrence was associated with pN2 (OR 1.99, 95% CI 1.0-4.1), and pN3 (OR 7.2, 95% CI 4.0-13.7). Patients who had local recurrence had similar OS to those without (HR 1.5, 95% CI 0.6-3.8), and worse OS was identified in patients with inguinal (HR 4.5, 95% CI 2.8-7.1), pelvic (HR 2.6, 95% CI 1.5-4.5), or distant (HR 4.0, 95% CI 2.7-5.8) recurrences. Patients with lung recurrences had worse OS than other sites (HR 2.2, 95% CI 1.1-4.3). CONCLUSIONS: Of the patients 31.9% had post-ILND recurrence associated with high pN staging. Greater than 95% of distant, inguinal, and pelvic recurrences occurred within 48 months, suggesting surveillance beyond this is low yield. Local recurrences occurred over a longer timeline, emphasizing necessity of long-term surveillance of the primary site. ispartof: JOURNAL OF UROLOGY vol:206 issue:4 pages:960-968 ispartof: location:United States status: published

Details

ISSN :
15273792
Volume :
206
Issue :
4
Database :
OpenAIRE
Journal :
The Journal of urology
Accession number :
edsair.doi.dedup.....0d824dcf6e4ed9c15d1d666319592d61